BACKGROUND: In November 2006, an outbreak of waterborne tularemia occurred in an eastern region in the Republic of Georgia. Outbreak investigation revealed 26 cases: 21 oropharyngeal and 5 glandular tularemia cases. METHODS: The presentation of the index case triggered an outbreak investigation involving the collection of clinical/ epidemiological data, application of tularine skin test, and laboratory confirmation of the possible cases using the tube agglutination test and polymerase chain reaction (PCR) testing. Serology results were verified by enzyme-linked immunosorbent assay (ELISA) and Western blot. A case- control study along with follow-up was conducted 4 months after the index case presentation. RESULTS: Exudative pharyngitis, predominantly laterocervical adenitis, fever, and headache were the most prevalent clinical signs/symptoms observed. Depressed mood, concentration difficulties, and sleep disturbance were also detected. Bubo aspirates tested by PCR were positive in 4/4 cases and pharyngeal swabs also tested by PCR were positive in 2/3 cases. Francisella tularensis was isolated from the water samples. Comparison of the cases and controls did not reveal any statistically significant risk factors. A follow-up investigation revealed cases with protracted symptoms of fatigue, headache, and sleep disturbance. Additionally, 8/26 cases still had cervical adenopathy of prominent size. A delay in diagnosis was associated with persistent lymphadenopathy on follow-up examination (p = 0.05). CONCLUSION: We observed unique features of persistent neuropsychiatric symptoms and lymphadenopathy 5 months after tularemia infection which were associated with delayed diagnosis and the lack of prompt response to therapy. This outbreak of oropharyngeal tularemia emphasizes the importance of a rapid diagnostic and investigative response to tularemia. This type of response can prevent ongoing exposure, as well as provide expeditious treatment to mitigate persistent symptoms.
BACKGROUND: In November 2006, an outbreak of waterborne tularemia occurred in an eastern region in the Republic of Georgia. Outbreak investigation revealed 26 cases: 21 oropharyngeal and 5 glandular tularemia cases. METHODS: The presentation of the index case triggered an outbreak investigation involving the collection of clinical/ epidemiological data, application of tularine skin test, and laboratory confirmation of the possible cases using the tube agglutination test and polymerase chain reaction (PCR) testing. Serology results were verified by enzyme-linked immunosorbent assay (ELISA) and Western blot. A case- control study along with follow-up was conducted 4 months after the index case presentation. RESULTS: Exudative pharyngitis, predominantly laterocervical adenitis, fever, and headache were the most prevalent clinical signs/symptoms observed. Depressed mood, concentration difficulties, and sleep disturbance were also detected. Bubo aspirates tested by PCR were positive in 4/4 cases and pharyngeal swabs also tested by PCR were positive in 2/3 cases. Francisella tularensis was isolated from the water samples. Comparison of the cases and controls did not reveal any statistically significant risk factors. A follow-up investigation revealed cases with protracted symptoms of fatigue, headache, and sleep disturbance. Additionally, 8/26 cases still had cervical adenopathy of prominent size. A delay in diagnosis was associated with persistent lymphadenopathy on follow-up examination (p = 0.05). CONCLUSION: We observed unique features of persistent neuropsychiatric symptoms and lymphadenopathy 5 months after tularemia infection which were associated with delayed diagnosis and the lack of prompt response to therapy. This outbreak of oropharyngeal tularemia emphasizes the importance of a rapid diagnostic and investigative response to tularemia. This type of response can prevent ongoing exposure, as well as provide expeditious treatment to mitigate persistent symptoms.
Authors: P Anda; J Segura del Pozo; J M Díaz García; R Escudero; F J García Peña; M C López Velasco; R E Sellek; M R Jiménez Chillarón; L P Sánchez Serrano; J F Martínez Navarro Journal: Emerg Infect Dis Date: 2001 Impact factor: 6.883
Authors: Katherine A Feldman; Donna Stiles-Enos; Kathleen Julian; Bela T Matyas; Sam R Telford; May C Chu; Lyle R Petersen; Edward B Hayes Journal: Emerg Infect Dis Date: 2003-03 Impact factor: 6.883
Authors: Ky V Hoang; Heather Curry; Michael A Collier; Hassan Borteh; Eric M Bachelder; Larry S Schlesinger; John S Gunn; Kristy M Ainslie Journal: Antimicrob Agents Chemother Date: 2016-03-25 Impact factor: 5.191
Authors: David R Williamson; Kalyan K Dewan; Tanmay Patel; Catherine M Wastella; Gang Ning; Girish S Kirimanjeswara Journal: Appl Environ Microbiol Date: 2018-02-14 Impact factor: 4.792
Authors: Gvantsa Chanturia; Dawn N Birdsell; Merab Kekelidze; Ekaterine Zhgenti; George Babuadze; Nikoloz Tsertsvadze; Shota Tsanava; Paata Imnadze; Stephen M Beckstrom-Sternberg; James S Beckstrom-Sternberg; Mia D Champion; Shripad Sinari; Miklos Gyuranecz; Jason Farlow; Amanda H Pettus; Emily L Kaufman; Joseph D Busch; Talima Pearson; Jeffrey T Foster; Amy J Vogler; David M Wagner; Paul Keim Journal: BMC Microbiol Date: 2011-06-17 Impact factor: 3.605
Authors: N Akhvlediani; I Burjanadze; D Baliashvili; T Tushishvili; M Broladze; A Navdarashvili; S Dolbadze; N Chitadze; M Topuridze; P Imnadze; N Kazakhashvili; T Tsertsvadze; T Kuchuloria; T Akhvlediani; L-A McNutt; G Chanturia Journal: Epidemiol Infect Date: 2018-09-25 Impact factor: 4.434